A breakthrough in the fight against cancer: Polish company to use artificial intelligence in diagnostics
Polish technology company Proacta has partnered with Ares Thera to create a modern tool for fighting cancer. The project is based on the use of artificial intelligence (AI), which is intended to help doctors detect lesions in patients faster and more accurately.
New technology is designed to analyze medical test results in real time. Thanks to advanced algorithms, the system will be able to spot irregularities that may be difficult for the human eye to perceive. This solution could significantly shorten the waiting time for a diagnosis, which is crucial for the effective treatment of oncological diseases.
Experts emphasize that the use of artificial intelligence in the Polish healthcare system is an important step toward modern medicine. The collaboration between the companies aims not only to improve the quality of examinations but also to unburden radiologists, who analyze thousands of diagnostic images every day.
The project is currently in a phase of intensive development. Representatives of both companies announce that the first clinical trials of the system could begin in the near future. If the results are positive, this technology could reach Polish hospitals and clinics within the next few years.
This initiative shows how modern technologies can realistically influence the improvement of patients' quality of life. The development of AI-supported diagnostics is an opportunity for more and more people in Poland to receive medical help at an early stage of the disease, which significantly increases the chances of a full recovery.